Critical Therapeutics.
Privately held biopharmaceutical company focused on critical care medicine.
Launch date
Market cap
-
Enterprise valuation
$224—336m (Dealroom.co estimates Oct 2003.)
Lexington Kentucky (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$10.0m | Series A | ||
$56.0m | Series B | ||
N/A | Acquisition | ||
Total Funding | $66.0m |
Recent News about Critical Therapeutics.
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.